Axatilimab Trial Results

Evaluating the significance of the AGAVE-201 trial results for axatilimab in refractory chronic GvHD and key factors to consider when assessing the data.

EP: 1.Treatment Goals and Options for Chronic GvHD

EP: 2.Appropriateness of Initial Therapy for Chronic GvHD

EP: 3.Efficacy and Safety of Emerging Therapies

EP: 4.Safety Profile of GVHD Treatment Options

EP: 5.Monitoring and Mitigating Adverse Events

EP: 6.Quality of Life Impact

Now Viewing

EP: 7.Axatilimab Trial Results

EP: 8.Future Landscape of cGvHD Management

Recent Videos